Complement-targeted therapeutics in periodontitis

Advances in Experimental Medicine and Biology

Volumn 734, Issue , 2013, Pages 197-206

  Hajishengallis, George ^a   Lambris, John D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A RECEPTOR; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5 INHIBITOR; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C5B; COMPLEMENT RECEPTOR; CYCLIC AMP; PMX 53; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; COMPLEMENT COMPONENT C5A RECEPTOR ANTAGONIST; COMPLEMENT INHIBITOR;

ANTIBACTERIAL ACTIVITY; BACTERIAL CLEARANCE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONFERENCE PAPER; DRUG TARGETING; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; MOUTH FLORA; NONHUMAN; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN FUNCTION; BIOFILM; CLINICAL FEATURE; DISEASE ASSOCIATION; HISTOPATHOLOGY; OSTEOLYSIS;

EID: 84934434579     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-4118-2_13     Document Type: Conference Paper

References (74)

1. Armitage GC (2002) Classifying periodontal diseases - a long-standing dilemma. Periodontol 2000 30:9-233
2. Bamberg CE, Mackay CR, Lee H, Zahra D, Jackson J, Lim YS, Whitfeld PL, Craig S, Corsini E, Lu B, Gerard C, Gerard NP (2010) The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J Biol Chem 285:7633-76444
3. Beikler T, Peters U, Prior K, Eisenacher M, Flemmig TF (2008) Gene expression in periodontal tissues following treatment. BMC Med Genomics 1:300
4. Brown LJ, Johns BA, Wall TP (2002) The economics of periodontal diseases. Periodontol 2000 29:223-2344
5. Brown JH, Whitham TG, Morgan Ernest SK, Gehring CA (2001) Complex species interactions and the dynamics of ecological systems: long-term experiments. Science 293:643-6500
6. Burns E, Bachrach G, Shapira L, Nussbaum G (2006) Cutting edge: TLR2 is required for the innate response to Porphyromonas gingivalis : activation leads to bacterial persistence and TLR2 Deficiency attenuates induced alveolar bone resorption. J Immunol 177:8296-83000
7. Chai L, Song Y-Q, Zee K-Y, Leung WK (2010) Single nucleotide polymorphisms of complement component 5 and periodontitis. J Periodont Res 45:301-3088
8. Chang M, Rowland CM, Garcia VE, Schrodi SJ, Catanese JJ, van der Helm-van Mil AH, Ardlie KG, Amos CI, Criswell LA, Kastner DL, Gregersen PK, Kurreeman FA, Toes RE, Huizinga TW, Seldin MF, Begovich AB (2008) A large-scale rheumatoid arthritis genetic study identi fies association at chromosome 9q33.2. PLoS Genet 4:e10001077
9. Coats SR, Jones JW, Do CT, Braham PH, Bainbridge BW, To TT, Goodlett DR, Ernst RK, Darveau RP (2009) Human toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4 ¢ -phosphatase activities. Cell Microbiol 11:1587-15999
10. Courts FJ, Boackle RJ, Fudenberg HH, Silverman MS (1977) Detection of functional complement components in gingival crevicular fluid from humans with periodontal diseases. J Dent Res 56:327-3311
11. de Haas CJC, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJB, Heezius ECJM, Poppelier MJJG, Van Kessel KPM, van Strijp JAG (2004) Chemotaxis inhibitory protein of Staphylococcus aureus , a bacterial antiinflammatory agent. J Exp Med 199:687-6955
12. de Pablo P, Chapple IL, Buckley CD, Dietrich T (2009) Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol 5:218-2244
13. Delima AJ, Van Dyke TE (2003) Origin and function of the cellular components in gingival crevice fluid. Periodontol 2000 31:55-766
14. Dunkelberger JR, Song WC (2010) Complement and its role in innate and adaptive immune responses. Cell Res 20:34-500
15. Ebenman B, Jonsson T (2005) Using community viability analysis to identify fragile systems and keystone species. Trends Ecol Evol 20:568-5755
16. Gaffen SL, Hajishengallis G (2008) A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res 87:817-8288
17. Genco RJ, Van Dyke TE (2010) Prevention: reducing the risk of CVD in patients with periodontitis. Nat Rev Cardiol 7:479-4800
18. Gibson FC III, Yumoto H, Takahashi Y, Chou HH, Genco CA (2006) Innate immune signaling and Porphyromonas gingivalis -accelerated atherosclerosis. J Dent Res 85:106-1211
19. Graves D (2008) Cytokines that promote periodontal tissue destruction. J Periodontol 79:1585-15911
20. Guo RF, Ward PA (2005) Role of C5a in inflammatory responses. Annu Rev Immunol 23:821-8522
21. Hajishengallis G (2009a) Porphyromonas gingivalis -host interactions: open war or intelligent guerilla tactics? Microbes Infect 11:637-6455
22. Hajishengallis G (2009b) Toll gates to periodontal host modulation and vaccine therapy. Periodontol 20000 51:181-2077
23. Hajishengallis G (2010) Complement and periodontitis. Biochem Pharmacol 80:1992-20011
24. Hajishengallis G, Lambris JD (2010) Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol 31:154-1633
25. Hajishengallis G, Lambris JD (2011) Microbial manipulation of receptor crosstalk in innate immunity. Nat Rev Immunol 11:187-2000
26. Hajishengallis G, Shakhatreh M-AK, Wang M, Liang S (2007) Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo. J Immunol 179:2359-23677
27. Hajishengallis G, Wang M, Liang S, Trianta fi lou M, Trianta fi lou K (2008) Pathogen induction of CXCR4/TLR2 crosstalk impairs host defense function. Proc Natl Acad Sci USA 105:13532-135377
28. Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, McIntosh ML, Alsam A, Kirkwood KL, Lambris JD, Darveau RP, Curtis MA (2011) Low-abundance bio film species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10:497-5066
29. Harboe M, Mollnes TE (2008) The alternative complement pathway revisited. J Cell Mol Med 12:1074-10844
30. Hillebrandt S, Wasmuth HE, Weiskirchen R, Hellerbrand C, Keppeler H, Werth A, Schirin-Sokhan R, Wilkens G, Geier A, Lorenzen J, Kohl J, Gressner AM, Matern S, Lammert F (2005) Complement factor 5 is a quantitative trait gene that modifies liver fi brogenesis in mice and humans. Nat Genet 37:835-8433
31. Holers VM (2008) The spectrum of complement alternative pathway-mediated diseases. Immunol Rev 223:300-3166
32. Kanazawa N, Furukawa F (2007) Autoinflammatory syndromes with a dermatological perspective. J Dermatol 34:601-6188
33. Kasama T, Miwa Y, Isozaki T, Odai T, Adachi M, Kunkel SL (2005) Neutrophil-derived cytokines: potential therapeutic targets in in flammation. Curr Drug Targets Inflamm Allergy 4:273-2799
34. Kebschull M, Demmer RT, Papapanou PN (2010) "Gum bug leave my heart alone" - epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J Dent Res 89:879-9022
35. Kimura Y, Miwa T, Zhou L, Song W-C (2008) Activator-specific requirement of properdin in the initiation and ampli fication of the alternative pathway complement. Blood 111:732-7400
36. Kinane DF, Peterson M, Stathopoulou PG (2006) Environmental and other modifying factors of the periodontal diseases. Periodontol 2000 40:107-1199
37. Kitsis E, Weissmann G (1991) The role of the neutrophil in rheumatoid arthritis. Clin Orthop Relat Res 265:63-722
38. Krauss JL, Potempa J, Lambris JD, Hajishengallis G (2010) Complementary tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host. Periodontol 2000 52:141-1622
39. Kumpf O, Schumann RR (2008) Genetic in fluence on bloodstream infections and sepsis. Int J Antimicrob Agents 32(Suppl 1):S44-S500
40. Lange D, Schroeder HE (1971) Cytochemistry and ultrastructure of gingival sulcus cells. Helv Odontol Acta 15:65-866
41. Liang S, Krauss JL, Domon H, McIntosh ML, Hosur KB, Qu H, Li F, Tzekou A, Lambris JD, Hajishengallis G (2011) The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J Immunol 186:869-8777
42. Newman HN (1980) Neutrophils and IgG at the host-plaque interface on children's teeth. J Periodontol 51:642-6511
43. Niekrash CE, Patters MR (1986) Assessment of complement cleavage in gingival fluid in humans with and without periodontal disease. J Periodont Res 21:233-2422
44. Nikolopoulou-Papaconstantinou AA, Johannessen AC, Kristoffersen T (1987) Deposits of immunoglobulins, complement, and immune complexes in in fl amed human gingiva. Acta Odontol Scand 45:187-1933
45. Nussbaum G, Shapira L (2011) How has neutrophil research improved our understanding of periodontal pathogenesis? J Clin Periodontol 38:49-599
46. Okroj M, Heinegard D, Holmdahl R, Blom AM (2007) Rheumatoid arthritis and the complement system. Ann Med 39:517-5300
47. Okuda K, Kimizuka R, Abe S, Kato T, Ishihara K (2005) Involvement of periodontopathic anaerobes in aspiration pneumonia. J Periodontol 76:2154-21600
48. Patters MR, Niekrash CE, Lang NP (1989) Assessment of complement cleavage in gingival fluid during experimental gingivitis in man. J Clin Periodontol 16:33-377
49. Pihlstrom BL, Michalowicz BS, Johnson NW (2005) Periodontal diseases. Lancet 366:1809-18200
50. Popadiak K, Potempa J, Riesbeck K, Blom AM (2007) Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. J Immunol 178:7242-72500
51. Potempa J, Pike RN (2009) Corruption of innate immunity by bacterial proteases. J Innate Immun 1:70-877
52. Power ME, Tilman D, Estes JA, Menge BA, Bond WJ, Mills LS, Daily G, Castilla JC, Lubchenco J, Paine RT (1996) Challenges in the quest for keystones. Bioscience 46:609-6200
53. Rautemaa R, Meri S (1996) Protection of gingival epithelium against complement-mediated damage by strong expression of the membrane attack complex inhibitor protectin (CD59). J Dent Res 75:568-5744
54. Ricklin D, Lambris JD (2007) Complement-targeted therapeutics. Nat Biotechnol 25:1265-12755
55. Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11:785-7977
56. Roberts A, Shah M, Chapple IL (2003) C-1 esterase inhibitor dysfunction localised to the periodontal tissues: clues to the role of stress in the pathogenesis of chronic periodontitis? J Clin Periodontol 30:271-2777
57. Scannapieco FA, Dasanayake AP, Chhun N (2010) Does periodontal therapy reduce the risk for systemic diseases? Dent Clin North Am 54:163-1811
58. Schenkein HA, Genco RJ (1977) Gingival fluid and serum in periodontal diseases. II. Evidence for cleavage of complement components C3, C3 proactivator (factor B) and C4 in gingival fluid. J Periodontol 48:778-7844
59. Schroeder HE, Listgarten MA (1997) The gingival tissues: the architecture of periodontal protection. Periodontol 20000 13:91-1200
60. Seppanen M, Lokki ML, Notkola IL, Mattila K, Valtonen V, Nieminen A, Vesanen M, Asikainen S, Meri S (2007) Complement and c4 null alleles in severe chronic adult periodontitis. Scand J Immunol 65:176-1811
61. Serhan CN, Chiang N, Van Dyke TE (2008) Resolving in flammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349-3611
62. Simpson JL, Phipps S, Gibson PG (2009) Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis. Pharmacol Ther 124:86-955
63. Slaney JM, Curtis MA (2008) Mechanisms of evasion of complement by Porphyromonas gingivalis . Front Biosci 13:188-1966
64. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr (1998) Microbial complexes in subgingival plaque. J Clin Periodontol 25:134-1444
65. Spitzer D, Mitchell LM, Atkinson JP, Hourcade DE (2007) Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J Immunol 179:2600-26088
66. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, Suvan J, Hingorani AD, Vallance P, Dean fi eld J (2007) Treatment of periodontitis and endothelial function. N Engl J Med 356:911-9200
67. Vitkov L, Klappacher M, Hannig M, Krautgartner WD (2010) Neutrophil fate in gingival crevicular fluid. Ultrastruct Pathol 34:25-300
68. Wagner E, Frank MM (2010) Therapeutic potential of complement modulation. Nat Rev Drug Discov 9:43-566
69. Wang M, Shakhatreh M-AK, James D, Liang S, S-i N, Yoshimura F, Demuth DR, Hajishengallis G (2007) Fimbrial proteins of Porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages. J Immunol 179:2349-23588
70. Wang M, Krauss JL, Domon H, Hosur KB, Liang S, Magotti P, Trianta fi lou M, Trianta fi lou K, Lambris JD, Hajishengallis G (2010) Microbial hijacking of complement-toll-like receptor crosstalk. Sci Signal 3:ra111
71. Ward PA (2009) Functions of C5a receptors. J Mol Med 87:375-3788
72. Wingrove JA, DiScipio RG, Chen Z, Potempa J, Travis J, Hugli TE (1992) Activation of complement components C33, and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis . J Biol Chem 267:18902-189077
73. Zhang X, Kimura Y, Fang C, Zhou L, Sfyroera G, Lambris JD, Wetsel RA, Miwa T, Song WC (2007) Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110:228-2366
74. Zhang X, Schmudde I, Laumonnier Y, Pandey MK, Clark JR, Konig P, Gerard NP, Gerard C, Wills-Karp M, Kohl J (2010) A critical role for C5L2 in the pathogenesis of experimental allergic asthma. J Immunol 185:6741-67522